Michael C. Feld is a seasoned executive in the medical technology and life sciences industry, currently serving as Executive Vice President, Chief Revenue Officer, and President of the Life Sciences Segment at Becton Dickinson and Company (BD), a global leader in medical devices and diagnostics. With over two decades of experience in healthcare and biotechnology, Feld began his career in sales and marketing roles at pharmaceutical firms, where he honed his expertise in driving revenue growth and fostering strategic partnerships. He holds a Bachelor's degree in Business Administration from the University of Pennsylvania's Wharton School and an MBA from Harvard Business School, which provided a strong foundation for his ascent in corporate leadership. Prior to joining BD, Feld held key positions at companies like Johnson & Johnson and Thermo Fisher Scientific, where he led initiatives that expanded market share in emerging biotech sectors and navigated complex regulatory environments. Throughout his career, Feld has been recognized for his innovative approaches to revenue optimization and segment leadership. At BD, he has spearheaded the Life Sciences Segment's transformation, overseeing a portfolio that includes advanced diagnostics, biosciences, and integrated systems for research and clinical applications. Under his guidance, the segment achieved record revenue growth, exceeding $5 billion annually, through strategic acquisitions, product launches, and global expansion efforts. Feld's achievements include negotiating multimillion-dollar partnerships with leading research institutions and implementing data-driven sales strategies that enhanced customer engagement and market penetration. His leadership has been instrumental in advancing BD's mission to improve patient outcomes worldwide, earning him accolades such as the Healthcare Executive of the Year award from industry associations. In his current role, Feld is responsible for aligning BD's revenue strategies with its overall corporate objectives, focusing on innovation in life sciences to address global health challenges like infectious diseases and personalized medicine. He champions sustainability initiatives within the segment, promoting eco-friendly manufacturing practices and digital health solutions. Feld's vision continues to drive BD's competitive edge in a rapidly evolving industry, positioning the company as a frontrunner in medical technology advancements.